Galantamine / BChE Cancer Research Results
Gala, Galantamine: Click to Expand ⟱
| Features: |
Galantamine
FDA approved drug for mild to moderate Alzheimer's Disease
- AChE inhibitor (reversible, competitive)
-May improve memory, cognition, and behavior
|
BChE, butyrylcholinesterase: Click to Expand ⟱
| Source: |
| Type: |
BChE is an enzyme that hydrolyzes choline-based esters. In the brain, it works alongside acetylcholinesterase (AChE) to regulate levels of the neurotransmitter acetylcholine. Since cholinergic deficits are a hallmark of AD, both enzymes have been studied in relation to AD pathology.
- In some AD patients, BChE activity increases relative to AChE.
- Aβ neurotoxicity is amplified when BChE is added to Aβ in tissue culture
|
Scientific Papers found: Click to Expand⟱
*BChE↓, *AChE↓, *Ach↑, *cognitive↑, *memory↑, *ROS↓, *Inflam↓, *NF-kB↓, *COX2?,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Total Targets: 0
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
ROS↓, 1,
Transcription & Epigenetics ⓘ
Ach↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2?, 1, Inflam↓, 1, NF-kB↓, 1,
Synaptic & Neurotransmission ⓘ
AChE↓, 1, BChE↓, 1,
Functional Outcomes ⓘ
cognitive↑, 1, memory↑, 1,
Total Targets: 9
Scientific Paper Hit Count for: BChE, butyrylcholinesterase
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:344 Target#:606 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page